The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 15, 2026
During the third quarter of 2026, the Ariel Appreciation Fund recorded a net return of -3.90% for its Investor Class shares, underperforming both the Russell Midcap Value Index benchmark return of -1.98% and the broader Russell Midcap Index return of -3.00%. Over the longer term, the strategy delivered net annualized returns of +13.88%, +6.25%, and +8.15% across the 1-, 5-, and 10-year periods, respectively. While headline domestic equity gauges advanced during the period, performance across broader mid-cap equities faced intense headwinds from escalating Treasury yields and interest rate pressures, prompting the strategy to maintain an active, disciplined, and patient approach toward deeply discounted fundamental value without taking on excessive structural leverage. The investment team highlights an increasingly bifurcated equity landscape characterized by extreme market concentration in mega-cap technology and artificial intelligence beneficiaries, contrasting sharply with compressed valuations across the rest of the equity universe. Persistent inflation, resilient macroeconomic expansion, and an additional Federal Reserve rate hike in September have created a restrictive cost-of-capital backdrop that disproportionately impacts mid-capitalization enterprises. Nevertheless, Ariel views this volatility and valuation bifurcation constructively, observing that broader market disconnects from long-term fundamental business earnings provide a fertile ground for patient capital allocations. Portfolio turnover during the quarter reflected proactive tax-loss harvesting and selective capital redeployment into high-quality franchise compounders. Top performers included Charles River Laboratories, Haemonetics Corporation, and Bio-Rad Laboratories, which advanced on robust operating results and guidance increases. Conversely, detractor OneSpaWorld Holdings was pressured by profit-taking, while Middleby Corporation softened despite organic volume gains. Ariel eliminated its stake in Norwegian Cruise Line Holdings to harvest tax losses and redeployed the capital into Royal Caribbean Group, fully divested Fiserv, and exited newly spun-off Midera Food Processing, while establishing a new position in ADI Global Distribution following its corporate separation from Resideo Technologies.
Exploit market bifurcations and short-term volatility by investing patiently in high-quality mid-cap companies boasting durable moats, strong balance sheets, and substantial long-term cash generation capabilities.
Looking forward, the tension between economic resilience and restrictive capital costs is expected to define the market environment. Market leadership may remain concentrated, yet this continues to create abundant opportunities among durable businesses that generate consistent cash flows and hold sound balance sheets. As market returns become increasingly governed by bottom-line earnings delivery rather than speculative multiple expansion, active and disciplined fundamental analysis is positioned to capitalize on share price volatility to acquire underappreciated intrinsic value.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Ariel Appreciation Fund or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.